Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2015-05-14 23:25 2015-05-12 COLL COLLEGIUM PHARMACEUTICAL, INC Longitude Capital Partners, LLC 10% owner Pharmaceutical Preparations BUY $12.00 200,000 $2,400,000 65,270 +100.0%
2015-05-15 04:24 2015-05-12 LIFE aTYR PHARMA INC AKKARAJU SRINIVAS Director, Other Biological Products, (No Diagnostic Substances) BUY $14.00 320,000 $4,480,000 1,866,126 +20.7%
2015-05-15 04:19 2015-05-12 LIFE aTYR PHARMA INC Sofinnova Venture Partners IX, L.P. 10% owner Biological Products, (No Diagnostic Substances) BUY $14.00 320,000 $4,480,000 1,866,126 +20.7%
2015-05-14 21:55 2015-05-12 COLL COLLEGIUM PHARMACEUTICAL, INC TPG Group Holdings (SBS) Advisors, Inc. Other Pharmaceutical Preparations BUY $12.00 100,000 $1,200,000 1,325,253 +8.2%
2015-05-14 23:06 2015-05-12 COLL COLLEGIUM PHARMACEUTICAL, INC Frazier Healthcare VI, L.P. 10% owner Pharmaceutical Preparations BUY $12.00 150,000 $1,800,000 1,887,332 +8.6%
2015-05-14 01:43 2015-05-13 RESI N/A Ellison George G Officer - President Other BUY $17.98 56,000 $1,007,154 56,000 +100.0%
2015-05-14 04:41 2015-05-12 COLL COLLEGIUM PHARMACEUTICAL, INC Skyline Venture Partners V LP 10% owner Pharmaceutical Preparations BUY $12.00 150,000 $1,800,000 2,949,916 +5.4%
2015-05-13 23:37 2015-05-12 COLL COLLEGIUM PHARMACEUTICAL, INC Hirsch David Director, 10% owner Pharmaceutical Preparations BUY $12.00 200,000 $2,400,000 65,270 +100.0%
2015-05-13 23:31 2015-05-12 COLL COLLEGIUM PHARMACEUTICAL, INC Freund John Gordon Director, 10% owner Pharmaceutical Preparations BUY $12.00 150,000 $1,800,000 2,949,916 +5.4%
2015-05-14 00:02 2015-05-11 LJPC N/A TANG KEVIN C Director, 10% owner Other BUY $18.24 190,583 $3,475,433 2,292,130 +9.1%
2015-05-13 23:36 2015-05-11 HTGM N/A Merck Capital Ventures LLC 10% owner Other BUY $14.00 167,343 $2,342,802 756,704 +28.4%
2015-05-13 23:20 2015-05-11 HTGM N/A Fletcher Spaght Ventures II LP 10% owner Other BUY $14.00 102,445 $1,434,230 518,595 +24.6%
2015-05-13 18:17 2015-05-05 FONU N/A Miguel Roger F. Director, Officer, 10% owner - Chief Executive Officer Other BUY $1,630.51 137,000 $223,379,993 211,955,212 +0.1%
2015-05-13 22:28 2015-05-05 FONU N/A Miguel Roger F. Director, Officer, 10% owner - Chief Executive Officer Other BUY $1,630.51 137,000 $223,379,993 965,796 +16.5%
2015-05-13 22:23 2015-02-12 FONU N/A Miguel Roger F. Director, Officer, 10% owner - Chief Executive Officer Other BUY $36,000.00 300,000 $10,800,000,000 828,796 +56.7%
2015-05-13 19:36 2015-05-11 HTGM N/A GLAXOSMITHKLINE PLC 10% owner Other BUY $14.00 365,106 $5,111,484 365,106 +100.0%
2015-05-13 23:05 2015-05-08 NLY ANNALY CAPITAL MANAGEMENT INC DENAHAN WELLINGTON Director, Officer - Chairman of Board & CEO Real Estate Investment Trusts BUY $10.04 198,216 $1,991,020 1,573,134 +14.4%
2015-05-12 23:43 2015-05-08 PN N/A Mariano Steven M. Director, Officer, 10% owner - See Remarks Other BUY $14.25 100,000 $1,424,700 695,108 +16.8%
2015-05-13 01:56 2015-03-06 NNVC NANOVIRICIDES, INC. BONIUK MILTON Director Pharmaceutical Preparations BUY $2.58 405,954 $1,045,656 1,455,391 +38.7%
2015-05-13 00:31 2015-05-11 CLCD N/A Novo A/S 10% owner Other BUY $10.00 1,300,000 $13,000,000 3,056,563 +74.0%
2015-05-13 00:21 2015-05-11 CLCD N/A Marengere Luc Director, 10% owner Other BUY $10.00 500,000 $5,000,000 1,495,386 +50.2%
2015-05-13 01:54 2015-05-08 OPGNOPGNW CapForce Inc. Versant Ventures III, LLC 10% owner Services-Medical Laboratories BUY $6.00 413,332 $2,479,992 2,853 +100.0%
2015-05-13 01:51 2015-05-08 OPGNOPGNW CapForce Inc. Ushio Misti Director Services-Medical Laboratories BUY $6.00 300,833 $1,804,998 330,716 +1,006.7%
2015-05-13 01:48 2015-05-08 OPGNOPGNW CapForce Inc. jVen Capital, LLC 10% owner Services-Medical Laboratories BUY $6.00 445,000 $2,670,000 445,000 +100.0%
2015-05-13 01:41 2015-05-08 OPGNOPGNW CapForce Inc. HARRIS & HARRIS GROUP INC /NY/ 10% owner Services-Medical Laboratories BUY $6.00 300,833 $1,804,998 330,716 +1,006.7%
2015-05-13 01:37 2015-05-08 OPGNOPGNW CapForce Inc. ATWOOD BRIAN G Director, 10% owner Services-Medical Laboratories BUY $6.00 413,332 $2,479,992 485,925 +569.4%
2015-05-13 00:06 2015-05-12 TEGP N/A DEHAEMERS DAVID G JR Director, Officer, 10% owner - President and CEO Other BUY $29.00 400,000 $11,600,000 400,000 +100.0%
2015-05-13 02:37 2015-05-11 CVX CHEVRON CORP STUMPF JOHN G Director Petroleum Refining BUY $108.10 180,000 $19,458,000 181,885 +9,549.1%
2015-05-13 00:25 2015-05-11 CLCD N/A PAPPAS ARTHUR M Director, 10% owner Other BUY $10.00 300,000 $3,000,000 116,317 +100.0%
2015-05-13 00:10 2015-05-12 TEGP N/A RAYMOND JOHN T Director, 10% owner Other BUY $29.00 235,000 $6,815,000 235,000 +100.0%
2015-05-13 00:32 2015-05-11 HTGM N/A Novo A/S 10% owner Other BUY $14.00 365,106 $5,111,484 1,280,185 +39.9%
2015-05-13 01:04 2015-05-08 WPRT WESTPORT FUEL SYSTEMS INC. DOUGLAS KEVIN 10% owner, Other Engines & Turbines BUY $5.89 250,000 $1,472,225 1,061,846 +30.8%
2015-05-13 03:48 2015-05-08 CMLS CUMULUS MEDIA INC CRESTVIEW RADIO INVESTORS, LLC Director, 10% owner Radio Broadcasting Stations BUY $2.31 807,173 $1,863,682 61,442,484 +1.3%
2015-05-12 16:12 2015-05-08 NLY ANNALY CAPITAL MANAGEMENT INC DENAHAN WELLINGTON Director, Officer - Chairman of Board & CEO Real Estate Investment Trusts BUY $10.04 184,948 $1,856,878 1,559,866 +13.5%
2015-05-13 01:46 2015-05-08 OPGNOPGNW CapForce Inc. JONES EVAN/ FA Officer - Chief Executive Officer Services-Medical Laboratories BUY $6.00 453,333 $2,719,998 8,333 +100.0%
2015-05-11 23:05 2015-05-08 N/A N/A Allegheny Technologies Inc Master Pension Trust 10% owner Other BUY $19.95 69,229 $1,381,119 1,127,185 +6.5%
2015-05-11 23:05 2015-05-08 N/A N/A AFA Sjukfoersaekringsaktiebolag 10% owner Other BUY $19.95 133,494 $2,663,205 2,164,121 +6.6%
2015-05-12 00:18 2015-05-07 HCOM N/A Twin Haven Capital Partners, L.L.C. 10% owner Other BUY $25.51 58,317 $1,487,568 470,921 +14.1%
2015-05-11 23:06 2015-05-08 N/A N/A State of Connecticut Retirement Plans & Trust Funds 10% owner Other BUY $19.95 148,347 $2,959,523 2,415,396 +6.5%
2015-05-11 23:48 2015-05-07 SHLD N/A BERKOWITZ BRUCE R 10% owner Other BUY $41.71 36,500 $1,522,327 26,138,348 +0.1%
2015-05-12 03:49 2015-05-08 QLYS QUALYS, INC. BERGERON SANDRA E. Director Services-Prepackaged Software BUY $37.51 50,000 $1,875,465 140,000 +55.6%
2015-05-11 22:40 2015-05-11 THRX Innoviva, Inc. GLAXOSMITHKLINE PLC 10% owner Pharmaceutical Preparations BUY $1,369,264.00 85,579 $117,180,243,856 31,759,432 +0.3%
2015-05-12 01:28 2015-05-07 RSG REPUBLIC SERVICES, INC. CASCADE INVESTMENT LLC 10% owner Refuse Systems BUY $40.05 1,350,000 $54,071,280 108,802,519 +1.3%
2015-05-11 23:45 2015-05-07 NS N/A GREEHEY WILLIAM E Director Other BUY $63.94 20,000 $1,278,898 2,791,366 +0.7%
2015-05-09 03:34 2015-05-06 BSM Black Stone Minerals, L.P. Sinclair Robert E. W. Director Crude Petroleum & Natural Gas BUY $19.00 250,500 $4,759,500 1,883,862 +15.3%
2015-05-09 04:49 2015-05-06 ZU N/A Alibaba Group Holding Ltd 10% owner Other BUY $11.67 4,812,425 $56,153,781 11,500,000 +72.0%
2015-05-09 01:31 2015-05-07 GNK GENCO SHIPPING & TRADING LTD Strategic Value Partners, LLC 10% owner Deep Sea Foreign Transportation of Freight BUY $7.00 300,000 $2,100,000 2,985,183 +11.2%
2015-05-08 03:21 2015-05-05 MAC MACERICH CO ONTARIO TEACHERS PENSION PLAN BOARD Director, 10% owner Real Estate Investment Trusts BUY $81.56 3,117,710 $254,286,039 20,258,555 +18.2%
2015-05-07 23:49 2015-05-05 BPMC N/A FMR LLC 10% owner, Other Other BUY $18.00 125,000 $2,250,000 2,500,711 +5.3%
2015-05-07 18:28 2015-05-05 GNK GENCO SHIPPING & TRADING LTD Strategic Value Partners, LLC 10% owner Deep Sea Foreign Transportation of Freight BUY $7.00 500,000 $3,500,000 2,890,615 +20.9%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.